15 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Reprocessed ViewFlex Xtra ICE Catheter (D087031)

FDA 510(k)
FDA Class 2 ·Cardiovascular

BD BBL™ Sensi-Disc™ Cefuroxime 30 µg

FDA UDI
BECTON, DICKINSON AND COMPANY·30382902316214·BD BBL™ Sensi-Disc™ Cefuroxime 30 µg

HERO 1, MODEL LY-ESB220

FDA 510(k)
FDA Class 2 ·Physical Medicine

Magicore II System

FDA 510(k)
FDA Class 2 ·Dental

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523156726·Tesera-k ALIF, 31W X 26D, 21mm, 17° Trial

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523151653·Tesera-k SA, 31mm X 26mm X 21mm, 17° Lordosis, T3

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523157471·Tesera-k ALIF, 31W X 26D, 21mm, 17° Broach

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·August 21, 2025

2.5MM DRILL BIT/QC/GOLD/110MM

FDA Adverse Event
Injury ·SYNTHES MONUMENT·Product code HWE·March 16, 2016

BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621¿

FDA Enforcement
Class II ·Ongoing·Becton Dickinson & Co.·February 14, 2024

G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code MDS·November 6, 2014

HIRES 90K

FDA Adverse Event
Malfunction ·ADVANCED BIONICS, LLC·Product code MCM·August 18, 2011

HOMECHOICE AUTOMATED PD SET WITH CASSETTE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - MOUNTAIN HOME·Product code FKX·July 17, 2013

BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621

FDA Recall
Open, Classified ·Becton Dickinson & Co.·Product code JTN·January 8, 2024

Revogene, Catalog no. 610210. IVD test instrument

FDA Enforcement
Class II ·Ongoing·Meridian Bioscience Inc·August 3, 2022